Thymosin Alpha-1

Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from the thymus gland that plays a key role in immune system modulation. It is approved in multiple countries for treating hepatitis B and C, and is researched for enhancing immune responses in immunocompromised states, cancer immunotherapy, and vaccine augmentation.